Goal Commitment and Proactive Health Behavior in Chronic Disease Patients

NCT07552571 | Recruiting

• 1 other identifier: SMHM-2026-01
• Study Type: interventional
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic diseases such as hypertension, diabetes, and dyslipidemia are major contributors to mortality and healthcare burden worldwide. Despite high awareness of health risks, many patients fail to adopt proactive health behaviors due to behavioral inertia and a gap between knowledge and action. This study aims to investigate the evolution and driving mechanisms of proactive health behavior in patients with chronic diseases based on goal commitment theory. By integrating prospect theory and evolutionary game theory, this study will explore how behavioral strategies evolve under different levels of goal commitment. In addition, a behavioral intervention based on the Stimulus-Organism-Response (SOR) model will be developed to enhance patient activation and promote adherence to proactive health behaviors. A parallel controlled intervention study will be conducted to evaluate the effectiveness of the goal commitment-based intervention. The findings of this study are expected to provide theoretical and practical evidence to improve chronic disease management and promote proactive health behaviors.

Conditions

Dyslipidemia; Diabetes Mellitus; Hypertension

Keywords

Proactive Health Behavior; Goal Commitment; Chronic Disease Management; Behavioral Intervention; Patient Activation; SOR Model

Outcome Measures

Primary Outcomes (1)

• Change in Proactive Health Behavior Score

  The primary outcome is the difference in the mean change of proactive health behavior scores between the intervention group and the control group at 6 months after the intervention. Proactive health behaviors will be assessed using a validated Proactive Health Behavior Scale, including overall score and component scores.

  Baseline to 6 months after intervention

Secondary Outcomes (12)

• Change in Metabolic Syndrome (MetS) Score

  Baseline to 6 months after intervention

• Change in Proactive Health Behavior Score at 3 Months

  Baseline to 3 months after intervention

• Change in Fasting Blood Glucose (FBG) at 3 Months

  Baseline to 3 months after intervention

• Change in Fasting Blood Glucose (FBG)

  Baseline, 3 months, and 6 months after intervention

• Change in Triglycerides (TG)

  Baseline, 3 months after intervention, and 6 months after intervention

Study Arms (2)

Goal Commitment Intervention Group

EXPERIMENTAL

Participants in this group will receive a goal commitment-based behavioral intervention designed to enhance proactive health behaviors. The intervention includes structured goal-setting, behavioral activation strategies, and continuous support to improve adherence to chronic disease management.

Behavioral: Goal Commitment-Based Behavioral Intervention

Usual Care Control Group

ACTIVE COMPARATOR

Participants in this group will receive routine chronic disease management or standard health education without additional behavioral intervention.

Other: Usual Care

Interventions

Goal Commitment-Based Behavioral Intervention BEHAVIORAL

This intervention is a structured behavioral program based on goal commitment theory, designed to promote proactive health behaviors in patients with chronic diseases. The intervention includes goal setting, personalized action planning, behavioral activation, and continuous follow-up support. Participants will receive guidance to enhance motivation, strengthen commitment to health goals, and improve adherence to chronic disease management through regular monitoring and feedback.

Goal Commitment Intervention Group

Usual Care OTHER

Participants in the control group will receive routine chronic disease management or standard health education without additional structured behavioral intervention.

Usual Care Control Group

Eligibility Criteria

• Age: 45 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Residents living in the study area for at least 1.5 years
• Diagnosed with at least one chronic disease, including hypertension, diabetes mellitus, or dyslipidemia
• Conscious and able to communicate effectively
• Educational level of primary school or above
• Able to use a smartphone and common mobile applications (e.g., WeChat)
• Willing to participate and provide written informed consent

You may not qualify if:

• Non-residents of the study area
• Unable to participate in group-based intervention activities
• Currently hospitalized
• Diagnosed with severe cognitive impairment, dementia, or psychiatric disorders
• Participants with severe comorbidities that may interfere with study participation

Sponsors & Collaborators

• Xiong Juyang: lead

Study Sites (1)

School of Medicine and Health Management Tongji Medical College,Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

RECRUITING

MeSH Terms

Conditions

Hypertension; Diabetes Mellitus; Dyslipidemias; Patient Participation

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Lipid Metabolism Disorders; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Central Study Contacts

Juyang Xiong, PhD

CONTACT

+86-13995629873; xiongjuyang@hust.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Participants will be assigned to either an intervention group or a control group in a parallel design. The intervention group will receive a goal commitment-based behavioral intervention, while the control group will receive routine chronic disease management or standard health education.

Study Record Dates

• First Submitted: April 16, 2026
• First Posted: April 27, 2026
• Study Start: May 15, 2025
• Primary Completion (Estimated): December 31, 2028
• Study Completion (Estimated): December 31, 2028
• Last Updated: May 6, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will share

Locations

CN (1)